Rebecca A Hubbard

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. pmc The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening
    Rebecca A Hubbard
    Group Health Research Institute Department of Biostatistics, School of Public Health, University of Washington and Group Health Permanente, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 22:1612-9. 2013
  2. pmc Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle models
    Monica Chaudhari
    Washington Dental Service, 9706 Fourth Avenue NE, Seattle, WA 98115, USA
    BMC Oral Health 12:20. 2012
  3. pmc A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring
    Rebecca A Hubbard
    Biostatistics Unit, Group Health Research Institute, Seattle, Washington 98101, USA
    Biometrics 69:245-53. 2013
  4. pmc Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography
    Rebecca A Hubbard
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 138:879-87. 2013
  5. pmc Effects of digital mammography uptake on downstream breast-related care among older women
    Rebecca A Hubbard
    Group Health Research Institute, Group Health Cooperative, Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA
    Med Care 50:1053-9. 2012
  6. pmc Modelling the cumulative risk of a false-positive screening test
    Rebecca A Hubbard
    Group Health Research Institute, Biostatistics Unit and Department of Biostatistics, University of Washington, Seattle, WA 98101, USA
    Stat Methods Med Res 19:429-49. 2010
  7. pmc Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study
    Rebecca A Hubbard
    Group Health Cooperative and School of Public Health of the University of Washington, Seattle, USA
    Ann Intern Med 155:481-92. 2011
  8. pmc Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age
    Ellen S O'Meara
    Group Health Research Institute, Seattle, Washington
    Cancer 119:3959-67. 2013
  9. pmc Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation
    Delia Scholes
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Avenue, 16th Floor, Seattle, Washington 98101, USA
    J Clin Endocrinol Metab 96:E1380-7. 2011
  10. pmc Distinguishing screening from diagnostic mammograms using medicare claims data
    Joshua J Fenton
    Departments of Family and Community Medicine, Radiology, and the Center for Healthcare Research and Policy, University of California Davis, Sacramento, CA Group Health Research Institute, Seattle, WA Departments of Radiology, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA Department of Biostatistics, University of Washington, Seattle, WA
    Med Care 52:e44-51. 2014

Collaborators

Detail Information

Publications11

  1. pmc The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening
    Rebecca A Hubbard
    Group Health Research Institute Department of Biostatistics, School of Public Health, University of Washington and Group Health Permanente, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 22:1612-9. 2013
    ..The objective of this study was to estimate the probability of experiencing a false-positive after receiving annual FOBT screening for 10 years...
  2. pmc Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle models
    Monica Chaudhari
    Washington Dental Service, 9706 Fourth Avenue NE, Seattle, WA 98115, USA
    BMC Oral Health 12:20. 2012
    ..This project had two purposes: to develop a methodology to estimate dental care utilization using claims data and to use this methodology to compare utilization of dental care between adults with and without diabetes...
  3. pmc A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring
    Rebecca A Hubbard
    Biostatistics Unit, Group Health Research Institute, Seattle, Washington 98101, USA
    Biometrics 69:245-53. 2013
    ..Models that provide accurate estimates under dependent censoring are critical for providing appropriate information for evaluating screening tests...
  4. pmc Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography
    Rebecca A Hubbard
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 138:879-87. 2013
    ..To guide health systems in their efforts to eliminate practices that do not contribute to effective care, we need further research to identify the causes of this variation and the best evidence-based approach for follow-up...
  5. pmc Effects of digital mammography uptake on downstream breast-related care among older women
    Rebecca A Hubbard
    Group Health Research Institute, Group Health Cooperative, Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA
    Med Care 50:1053-9. 2012
    ..Digital mammography is the dominant modality for breast cancer screening in the United States. No previous studies have investigated as to how introducing digital mammography affects downstream breast-related care...
  6. pmc Modelling the cumulative risk of a false-positive screening test
    Rebecca A Hubbard
    Group Health Research Institute, Biostatistics Unit and Department of Biostatistics, University of Washington, Seattle, WA 98101, USA
    Stat Methods Med Res 19:429-49. 2010
    ..The estimated risk of an FP recall after 10 screening mammograms varied between 58% and 77% depending on the approach used, with an estimate of 63% based on what we feel are the most reasonable modelling assumptions...
  7. pmc Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study
    Rebecca A Hubbard
    Group Health Cooperative and School of Public Health of the University of Washington, Seattle, USA
    Ann Intern Med 155:481-92. 2011
    ..False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could also delay cancer diagnosis...
  8. pmc Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age
    Ellen S O'Meara
    Group Health Research Institute, Seattle, Washington
    Cancer 119:3959-67. 2013
    ..Biennial screening mammography retains most of the benefits of annual breast cancer screening with reduced harms. Whether screening guidelines based on race/ethnicity and age would be more effective than age-based guidelines is unknown...
  9. pmc Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation
    Delia Scholes
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Avenue, 16th Floor, Seattle, Washington 98101, USA
    J Clin Endocrinol Metab 96:E1380-7. 2011
    ..Oral contraceptive (OC) use is common, but bone changes associated with use of contemporary OC remain unclear...
  10. pmc Distinguishing screening from diagnostic mammograms using medicare claims data
    Joshua J Fenton
    Departments of Family and Community Medicine, Radiology, and the Center for Healthcare Research and Policy, University of California Davis, Sacramento, CA Group Health Research Institute, Seattle, WA Departments of Radiology, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA Department of Biostatistics, University of Washington, Seattle, WA
    Med Care 52:e44-51. 2014
    ..However, it is uncertain whether claims data can accurately distinguish screening from diagnostic mammograms, particularly when claims are not linked with cancer registry data...
  11. ncbi request reprint Employee knowledge of value-based insurance design benefits
    Nora B Henrikson
    Group Health Research Institute, Seattle, Washington Electronic address
    Am J Prev Med 47:115-22. 2014
    ..Value-based insurance designs (VBD) incorporate evidence-based medicine into health benefit design. Consumer knowledge of new VBD benefits is important to assessing their impact on health care use...